Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$10.62 – $14.17
39% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $237.8M | $244.0M | $111.0M | $141.2M | $182.1M | $232.1M | $244.8M | $229.8M |
| Cost of revenue | $92.1M | $104.5M | $62.2M | $67.5M | $83.5M | $97.2M | $110.7M | $101.1M |
| Gross profit | $145.7M | $139.4M | $48.8M | $73.6M | $98.6M | $134.9M | $134.1M | $128.7M |
| Gross margin | 61.3% | 57.2% | 44.0% | 52.2% | 54.1% | 58.1% | 54.8% | 56.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $82.3M | $79.3M | $13.9M | $24.7M | $43.4M | $64.0M | $63.8M | $67.0M |
| EBITDA | $88.6M | $85.7M | $20.5M | $31.2M | $49.1M | $69.8M | $254.3M | $73.4M |
| Net income | $179.1M | $182.2M | $119.8M | $110.1M | $148.3M | $216.6M | $228.3M | $265.3M |
| Net margin | 75.3% | 74.7% | 107.9% | 78.0% | 81.5% | 93.3% | 93.2% | 115.4% |
| EPS (diluted) | 0.81 | 0.82 | 0.54 | 0.50 | 0.67 | 0.98 | 1.03 | 1.20 |
Annual figures · source: Financial Modeling Prep
HAW PAR CORP LTD SG1 ORD
No one on the platform currently holds HAWPF.
No tracked institution reports a position in HAWPF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-06 | $0.2000 | 2026-05-21 |
| 2025-08-21 | $0.2000 | 2025-09-11 |
| 2025-05-06 | $0.2000 | 2025-05-21 |
| 2025-05-06 | $1.0000 | 2025-05-21 |
| 2024-08-23 | $0.2000 | 2024-09-10 |
| 2024-05-03 | $0.2000 | 2024-05-21 |
| 2023-08-21 | $0.2000 | 2023-09-07 |
No one on the platform has traded HAWPF yet.
| +3.74% |
| $2.6B |
| — |
| DMPHFDermapharm Holding SE | $53.00 | +0.00% | $2.6B | — |
| HMDCFHUTCHMED (China) Limited | $2.16 | +0.00% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 7.3× earnings vs its 8.0× historical median P/E.
Fair value ≈ $13.21 · price $12.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.